≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Eye, unspecified (controls excluding all cancers)

Endpoint Browser PheWeb

CD2_EYE_NOS_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D31.9&
Hospital discharge: ICD-9 224[8-9]|2240
Hospital discharge: ICD-8 22409|22402
Cause of death: ICD-10 D31.9&
Cause of death: ICD-9 224[8-9]|2240
Cause of death: ICD-8 22409|22402

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

119

diagram downward connector
CD2_EYE_NOS_EXALLC

Control definitions

Control exclude C3_CANCER

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D31
Name in latin Neoplasma benignum oculi non specificatum

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 119 76 43
Unadjusted prevalence (%) 0.03 0.03 0.02
Mean age at first event (years) 54.86 53.31 57.61

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_EYE_NOS_EXALLC – Benign neoplasm: Eye, unspecified (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Benign neoplasm: Eye, unspecified (controls excluding all cancers)
after Benign neoplasm: Eye, unspecified (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Eye, unspecified (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.